ERFE was inversely associated with being overweight and abdominal obesity, but also with the occurrence of hypertriglyceridemia of ≥1.69 mmol/L (≥150 mg/dL), early insulin resistance defined by HOMA-IR > 2.0 and a CRP level > 1 mg/L, considered to be a moderate/high cardiovascular disease (CVD) risk factor. This evidence concerns the gene CRP and Abdominal obesity.